Presence of antiphospholipid antibodies tied to first-time MI

Presence of antiphospholipid antibodies tied to first-time MI
(HealthDay)—There is a strong and independent association between the presence of antiphospholipid antibodies (aPLs) and first-time myocardial infarction (MI), according to a research letter published recently in the Annals of Internal Medicine.

Giorgia Grosso, M.D., from the Karolinska Institutet in Stockholm, and colleagues assessed the frequency of anti-β2-glycoprotein (anti-β2GPI) and anticardiolipin (anti-CL) of immunoglobulin G (IgG)/IgA/IgM isotypes and among 805 patients with first-time MI (<75 years) and 805 matched control participants in a large multicenter study.

The researchers found that IgG anti-β2GPI and/or IgG anti-CL (aPL IgG-positive) were more common in patients with MI (11.1 percent) versus control participants (1.3 percent; P < 0.001). IgA/IgM isotypes did not differ. There was a strong correlation between anti-CL and anti-β2GPI of the same isotype. After adjustment for traditional risk factors, aPL IgG positivity (odds ratio, 7.8; P < 0.001) and current smoking (odds ratio, 2.6; P < 0.001) remained associated with MI, while diabetes, hypertension, and body mass index did not. Age did not differ among aPL IgG-positive and -negative patients with MI (P = 0.146), but aPL IgG positivity was nonsignificantly more common among women (P = 0.062) and current smokers (P = 0.085).

"If confirmed in long-term cohort studies, these findings may lead to improved management, treatment, and outcomes for many who have had or are at for MI," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Explore further

Antibodies linked to heart attacks

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Annals of Internal Medicine

Copyright © 2018 HealthDay. All rights reserved.

Citation: Presence of antiphospholipid antibodies tied to first-time MI (2018, December 3) retrieved 27 May 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more